Please login to the form below

Not currently logged in
Email:
Password:

Sanofi and Audion in hearing partnership

Sanofi has entered into a two-year research collaboration with the Audion Therapeutics to develop potential treatments for hearing loss

Sanofi has entered into a two-year research collaboration with the Audion Therapeutics to develop potential treatments for hearing loss through the optimisation of small molecules by using a regenerative medicine approach.

The research will use technology developed at the Massachusetts Eye and Ear Infirmary in the Eaton-Peabody Laboratory, a basic research facility dedicated to the study of hearing and deafness, by investigator and Audion co-founder Dr Albert Edge, who has strong expertise in stem cells and inner ear biology. Audion licensed Dr Edge's technology from Mass Eye and Ear. 

Under the terms of the agreement, Sanofi has an option to license technology rights from Audion related to research conducted under the collaboration.

<

Dr Elias Zerhouni, president of global R&D at Sanofi, said: "Our new relationship with Audion demonstrates our commitment to work with partners on conditions with unmet and growing medical needs, such as hearing loss.

"This collaboration is a multi-disciplinary approach with our internal Aging Therapeutic Strategic Unit and our Early-to-Candidate Unit working together to advance novel therapies in the field of otolaryngology using the most advanced technologies available to study cochlear biology," he added.

16th June 2011

Share

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Wilmington Healthcare

A heritage to envy Wilmington Healthcare brings together the data intelligence specialisms of Binley’s, NHiS, Wellards and HSJ to create...

Latest intelligence

Report: Reinventing product and portfolio value for the biopharmaceutical industry
Gain practical advice on determining and communicating product and portfolio value, including why, in fast-paced and evolving markets, you need to consider the evidence requirements of a growing network of...
Neil Thompson
How AI is finally helping rare diseases gain more than just attention
By Neil Thompson...
Is communication failing us?
Compelling people to care in a world oversaturated with news and information...